Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-12-18
2010-06-01
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07727977
ABSTRACT:
The present invention relates to the use of at least one compound with inhibitory activity on kynurenine 3-hydroxylase for the preparation of a medicament for the prevention and/or treatment of diabetes.
REFERENCES:
patent: 5877193 (1999-03-01), Cesura et al.
patent: 6143787 (2000-11-01), Moinet et al.
patent: 6288063 (2001-09-01), Ha et al.
patent: 6323240 (2001-11-01), Giordani et al.
patent: 6572542 (2003-06-01), Houben et al.
patent: 2003/0176476 (2003-09-01), Barf et al.
patent: 2009/0076006 (2009-03-01), Qian et al.
patent: 0 885 869 (1998-12-01), None
patent: WO 01/90092 (2001-11-01), None
Diabetes Research Foundation, “Diabetes and Your Eyesight,” printed from http://www.glaucoma.org/learn/diabetes—and—yo.html, 2 pages.
Naoki et al: “A Novel Enhancer of Insulinotrophic Action by High Glucose (JTT-608) Stimulates Insulin Secretion From Prancreatic Beta Cells Via a New Cellular Mechanism” Journal of Pharmacology and Experimental Therapeutics, vol. 297, No. 3, 2001, pp. 953-960.
Ohta, et al.: “JTT-608 Controls Blood Glucose by Enhancement of Glucose-Stimulated Insulin Secretion in Normal and Diabetes Mellitus Rats” European Journal of Pharmacology, vol. 367, 1999, pp. 91-99.
Shimizu, Makoto et al: “Stannous Triflate Promoted Rearrangement of beta.-keto sulfoxides. Synthesis of 1,4-Diketones” Chemistry Letters (1984) p. 1531-1534.
Kunkel, Elisabeth et al.: “Ring Opening Reactions of Methyl 2-Silyloxycyclopropanecarboxylates to 4-Oxoalkanoic Acid Derivatives” Liebigs Annalen Der Chemie (1984) p. 804.
Miyashita, Masaaki et al.: “Michael Reaction of Conjugated Nitro Olefins With Carboxylic Acid Dianion and With Ester Enolates: New Synthesis of gamma.-keto acids and gamma.-keto esters” Journal of Organic Chemistry (1984), pp. 2857-2863.
Marchand, Nathalie J. et al.: “Synthesis and Reactivity of Cross-Conjugated Polyenones With a Planar Chirality” Journal of Organic Chemistry (1996) pp. 5063-5072.
Tius, Marcus A. et al: “Synthesis of (.+-.)-xanthocidin” Tetrahedron (1996) pp. 14651-14660.
Tschesche, Rudolf et al: “Pteridines. XIV. The Synthesis of a Urothion Analog With a Methyl Side Chain” Chem. Ber (1956) pp. 89, 1054-1064.
Reissig, Hans Ulrich et al: “Selenylation, Sulfenylation, and Aminomethylation of Methyl 2-Siloxycyclopropanecarboxylates by Lewis Acid-Induced Ring Cleavage” Liebigs Annalen Der Chemie (1986) pp. 1914-1923.
Connick et al.: “The Role of Kynurenines in Diabetes Mellitus” Medical Hypotheses, vol. 18, No. 4, 1985, pp. 371-376.
Arbellot De Vacqueur Annick
Autier Valerie
Kargar Catherine
Kergoat Micheline
Mariais Dominique
Hughes Alicia R
Marschel Ardin
Merck Patent Gesellschaft mit beschrankter Haftung
Millien, White, Zelano & Branigan, P.C.
LandOfFree
Kynurenine 3-hydroxylase inhibitors for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kynurenine 3-hydroxylase inhibitors for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kynurenine 3-hydroxylase inhibitors for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4248319